- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$5.86 BnMarket Estimate, 2026
$6.33 BnMarket Forecast, 2034
$11.80 BnCAGR, 2026–2034
8.1%Latin America Lung Cancer Surgery Market Size, Growth, Trends & Forecast (2026–2034)
The Latin America lung cancer surgery market size was valued at USD 5.86 billion in 2025, is estimated to reach USD 6.33 billion in 2026, and is projected to hit USD 11.80 billion by 2034, registering a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2026 to 2034. Driven by rising pollution levels, increasing cigarette smoking rates, a growing geriatric population, and the escalating prevalence of lung cancer, the regional market continues to expand robustly.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 5.86 Billion
- 2026 Current Valuation: USD 6.33 Billion
- 2034 Forecast Valuation: USD 11.80 Billion
- Compound Annual Growth Rate (CAGR): 8.1% (2026–2034)
- Fastest-Growing Procedure Segment: Minimally Invasive Surgeries (driven by early detection awareness and clinical advantages)
- Dominant Device Segment: Surgical Instruments (due to shorter product lifespans and widespread adoption)
- Regional Highlights: The Latin American market is anticipated to show significant growth supported by increasing disposable incomes and improving healthcare facilities across countries like Mexico, Brazil, Argentina, and Chile.
Core Market Drivers
- Environmental & Lifestyle Factors: Increasing pollution levels and rising numbers of cigarette smokers accelerating cancer risks.
- Demographics & Disease Incidence: Expanding aging population coupled with a higher baseline incidence and prevalence of lung cancer.
- Economic & Infrastructure Upgrades: Rising disposable incomes and improving healthcare facilities facilitating advanced surgical treatments.
Primary Market Restraints & Challenges
- High Treatment Costs: The steep overall cost of lung cancer surgery acting as a restraint on market expansion.
Latin America Lung Cancer Surgery Market Segmentation Breakdown
| Segment Category | Sub-Segments Covered |
|---|---|
| By Procedure | Thoracotomy Lobectomy, Pneumonectomy, Sleeve Resection, Segmentectomy, Minimally Invasive |
| By Device | Surgical Clamps, Forceps, Retractors, Staplers, Cutters, Scissors, Elevators, RIB Sheers, Trocars, Monitoring Cameras, Video Support, Visualizing Systems, Endoscopic Trocars with Optical Views, Endo Surgical Equipment |
| By Country | Mexico, Brazil, Argentina, Chile, Rest of Latin America |
Major Industry Players Profiled
Prominent companies operating in the Latin American lung cancer surgery market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.
Download Free Sample Report
Latin America Lung Cancer Surgery Market Size
The Latin America Lung Cancer Surgery Market was valued at USD 5.86 billion in 2025, is estimated to reach USD 6.33 billion in 2026, and is projected to reach USD 11.80 billion by 2034, growing at a CAGR of 8.1% from 2026 to 2034.
The name of cancer is generally given by the name of the organ in which it starts. Lung Cancer is a type of cancer that starts in Lung tissue or its surrounding parts. There are various treatments available to treat lung cancer, like Chemotherapy, Radiotherapy, Laser Therapy, and Surgery. Surgery involves removing infected sections from the lung, and in some cases, a complete lung is removed. However, Surgery couldn’t be used if cancer cells are close to the heart.
Increasing pollution levels, rising number of cigarette smokers, rising incidence and prevalence of Lung Cancer, and rising geriatric population are major factors driving the market.
However, the high cost of Lung Cancer surgery is restraining the growth of the market.
Based on procedure, Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people for early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.
Based on the device, the Surgical Instruments segment is expected to dominate the market due to the shorter lifespan of devices and the wider adoption.
Geographically, the Latin American market is expected to show significant growth during the forecast period due to increasing disposable incomes and improving healthcare facilities.
KEY MARKET PLAYERS
Prominent companies operating in the LATAM Lung Cancer Surgery Market include
- Ethicon US LLC
- Intuitive Surgical Inc.
- AngioDynamics Inc.
- Olympus Corporation
- Accuray Inc.
- Ackermann Instrumente GmbH
- Teleflex Inc.
- KARL STORZ GmbH
- Scanlan International Inc.
- Trokamed GmbH
MARKET SEGMENTATION
This research report on the Latin American Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories.
By Procedure
- Thoracotomy
- Lobectomy
- Pneumonectomy
- Sleeve Resection
- Segmentectomy
- Minimally Invasive
By Device
- Surgical
- Clamps
- Forceps
- Retractors
- Staplers
- Cutters
- Scissors
- Elevators
- RIB Sheers
- Trocars
- Monitoring
- Cameras
- Video Support
- Visualizing Systems
- Endoscopic Trocars with Optical Views
- Endo Surgical Equipment
By Country
- Mexico
- Brazil
- Argentina
- Chile
- Rest of Latin America